Diverse functional autoantibodies in patients with COVID-19 EY Wang, T Mao, J Klein, Y Dai, JD Huck, JR Jaycox, F Liu, T Zhou, ... Nature 595 (7866), 283-288, 2021 | 835 | 2021 |
Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β A Metelli, BX Wu, B Riesenberg, S Guglietta, JD Huck, C Mills, A Li, ... Science translational medicine 12 (525), eaay4860, 2020 | 90 | 2020 |
Dynamic DNA binding licenses a repair factor to bypass roadblocks in search of DNA lesions MW Brown, Y Kim, GM Williams, JD Huck, JA Surtees, IJ Finkelstein Nature communications 7 (1), 10607, 2016 | 63 | 2016 |
Structural and functional analysis of GRP94 in the closed state reveals an essential role for the pre-N domain and a potential client-binding site JD Huck, NL Que, F Hong, Z Li, DT Gewirth Cell reports 20 (12), 2800-2809, 2017 | 62 | 2017 |
Plasmodium infection induces cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein S Lapidus, F Liu, A Casanovas-Massana, Y Dai, JD Huck, C Lucas, ... MedRxiv, 2021 | 33 | 2021 |
Early peak and rapid decline of SARS-CoV-2 seroprevalence in a Swiss metropolitan region M Emmenegger, E De Cecco, D Lamparter, RPB Jacquat, D Ebner, ... MedRxiv 531, 20118554, 2020 | 24 | 2020 |
NECA derivatives exploit the paralog-specific properties of the site 3 side pocket of Grp94, the endoplasmic reticulum Hsp90 JD Huck, NLS Que, RM Immormino, L Shrestha, T Taldone, G Chiosis, ... Journal of Biological Chemistry 294 (44), 16010-16019, 2019 | 17 | 2019 |
Exploring the functional complementation between Grp94 and Hsp90 KA Maharaj, NLS Que, F Hong, JD Huck, SK Gill, S Wu, Z Li, DT Gewirth PloS one 11 (11), e0166271, 2016 | 17 | 2016 |
Depletion of exhausted alloreactive T cells enables targeting of stem-like memory T cells to generate tumor-specific immunity SA Minnie, OG Waltner, KS Ensbey, NS Nemychenkov, CR Schmidt, ... Science immunology 7 (76), eabo3420, 2022 | 13 | 2022 |
Campbell EY Wang, T Mao, J Klein, Y Dai, JD Huck, F Liu, NS Zheng, Z TING, ... Fournier, JB, Wyllie, AL, CHANTAL BF Vogels, Ott IM, CHANEY C. Kalinich …, 2020 | 13 | 2020 |
Diverse Functional Autoantibodies in Patients with COVID-19. medRxiv 2020 EY Wang, T Mao, J Klein, Y Dai, JD Huck, F Liu, NS Zheng, T Zhou, ... Google Scholar, 2020 | 11 | 2020 |
Structures of Hsp90α and Hsp90β bound to a purine‐scaffold inhibitor reveal an exploitable residue for drug selectivity JD Huck, NLS Que, S Sharma, T Taldone, G Chiosis, DT Gewirth Proteins: Structure, Function, and Bioinformatics 87 (10), 869-877, 2019 | 11 | 2019 |
Population-wide evolution of SARS-CoV-2 immunity tracked by a ternary immunoassay M Emmenegger, E De Cecco, D Lamparter, RPB Jacquat, J Riou, ... | 9 | 2020 |
Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein S Lapidus, F Liu, A Casanovas-Massana, Y Dai, JD Huck, C Lucas, ... Scientific reports 12 (1), 22175, 2022 | 7 | 2022 |
IL-18BP mediates the balance between protective and pathological immune responses to Toxoplasma gondii JT Clark, OE Weizman, DL Aldridge, LA Shallberg, J Eberhard, Z Lanzar, ... Cell reports 42 (3), 2023 | 6 | 2023 |
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region M Emmenegger, E De Cecco, D Lamparter, RPB Jacquat, J Riou, ... Iscience 26 (2), 2023 | 6 | 2023 |
A host–microbiota interactome reveals extensive transkingdom connectivity ND Sonnert, CE Rosen, AR Ghazi, EA Franzosa, B Duncan-Lowey, ... Nature 628 (8006), 171-179, 2024 | 1 | 2024 |
1070 ‘Decoy-resistant’IL-18 in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma DA Schoenfeld, D Djureinovic, L Zhang, J Mann, J Huck, L Jilaveanu, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
A modified IL-18 drug in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma D Schoenfeld, D Djureinovic, L Zhang, J Mann, J Huck, L Jilaveanu, ... NaN, NaN-NaN, 2023 | | 2023 |
Recombinant grp94 chaperones and methods of using the same to modulate glycosylation in fusion proteins DT Gewirth, JD Huck US Patent App. 17/191,387, 2021 | | 2021 |